Bowel perforation in non-small cell lung cancer after bevacizumab therapy

Author： Schellhaas Elisabeth   Loddenkemper Christoph   Schmittel Alexander   Buhr Heinz-J.   Pohlen Uwe  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.27, Iss.2, 2009-04, pp. : 184-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab in Non-Small Cell Lung Cancer

By Francesco Di Costanzo  

Drugs, Vol. 68, Iss. 6, 2008-01 ,pp. : 737-746

Adis International

Access to resources Recommend Favorite

Bevacizumab AVAiLs in non-small cell lung cancer

By  

Inpharma, Vol. 1, Iss. 1593, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Non-small cell lung cancer: from targeted therapy to tailored therapy

By Malgieri Simona   Feliciano Salvatore   Bosso Davide   Federico Piera   Palmieri Giovannella   De Placido Sabino   Di Lorenzo Giuseppe   Buonerba Carlo  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 13, 2012-09 ,pp. : 1817-1819

Informa Healthcare

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

The Role of Induction Therapy for Resectable Non-Small Cell Lung Cancer

By Stinchcombe Thomas E.   Socinski Mark A.  

Drugs, Vol. 67, Iss. 3, 2007-01 ,pp. : 321-332

Adis International

Access to resources Recommend Favorite